Navigation Links
Amlodipine and Olmesartan Study Results Released; Late Breaker,Presented at American Society of Hypertension Twenty-Second Annual,Scientific Meeting (ASH 2007)

e: calcium channel blockade with amlodipine and angiotensin receptor blockade with olmesartan.

The AE profile for each of the combinations was similar in nature to the monotherapy components. Most reported treatment-emergent adverse events across all treatment groups were considered mild in severity.

Hypertension, also known as high blood pressure, affects approximately 72 million people in the United States and approximately one billion worldwide. It is often difficult to control, and of those diagnosed with high blood pressure, 64.9 percent do not have the condition under control.(1)

Study Design

The study was a Phase III, 8-week, randomized, double-blind, placebo- controlled, parallel-group, factorial study in 1,940 patients with mild to severe hypertension defined as seated diastolic BP between greater than or equal to 95 mm Hg and less than or equal to 120 mm Hg. The purpose of the study was to determine if co-administration of amlodipine 5-10 mg/day and olmesartan 10-20-40 mg/day had a significant benefit vs. its respective monotherapy components. Primary and one of the secondary endpoints were mean change from baseline in seated diastolic and seated systolic blood pressure at week 8, respectively.

About Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc., headquartered in Parsippany, New Jersey, is the U.S. subsidiary of Daiichi Sankyo Co., Ltd., Japan's second largest pharmaceutical company and a global leader in pharmaceutical innovation since 1899. The company is dedicated to the discovery, development and commercialization of innovative medicines that improve the lives of patients throughout the world.

The primary focus of Daiichi Sankyo's research and development is cardiovascular disease, including therapies for dyslipidemia, hypertension, diabetes, and acute coronary syndrome. The company is also pursuing the discovery of new medicines in the areas of glucose metabolic disorders, infectious diseases, cancer, bone
'"/>




Page: 1 2 3

Related medicine technology :

1. Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
2. Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage 2 Patients Compared With Amlodipine + Benazepril
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
5. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
Post Your Comments:
(Date:11/22/2014)... -- Statistics released from a number of organizations show ... the holidays, beginning with Thanksgiving eve, which is now ... The data, highlighted in an Infographic released ... their annual Sober Days for the Holidays public ... and increased rates of DUI injuries and deaths during ...
(Date:11/22/2014)... Research and Markets  has announced the addition ... 2014-2017" report to their offering. ... protein drug market has been expanding rapidly owing to ... like. During 2005-2013, sales of recombinant protein drugs available ... 19.1%, and it is projected that ...
(Date:11/21/2014)... 21, 2014  The University of Maryland,s A. James ... groundbreaking of the new A. James Clark Hall at ... will cultivate transformative new engineering and biomedical technologies to ... at 10:00 a.m. on November 21 at the site ... Lot, adjacent to the Jeong H. Kim Engineering Building, ...
Breaking Medicine Technology:Alarming Stats Show Holiday Drinking an Issue for Many 2China Recombinant Protein Drug Industry Report, 2014-2017 2China Recombinant Protein Drug Industry Report, 2014-2017 3University of Maryland Breaks Ground for A. James Clark Hall 2University of Maryland Breaks Ground for A. James Clark Hall 3University of Maryland Breaks Ground for A. James Clark Hall 4
... is natural that all customers using the services of online ... for them and getting their order within the shortest possible ... and well-taken. This site assures new and regular clients with ... security. It uses the most updated methods to make every ...
... HeartWare International, Inc. (Nasdaq: HTWR ) (ASX: ... support technologies that are revolutionizing the treatment of advanced ... scheduled to make an investor presentation at the Canaccord ... 2010 at 9:00 a.m. Pacific Time (noon, Eastern Time). ...
Cached Medicine Technology:A New Online Pharmacy rxbuys.com by RX Corp Offers its Services to International Clients 2HeartWare to Present at the Canaccord Genuity Cardio/Diabetes & Obesity Conference 2
(Date:11/23/2014)... (PRWEB) November 24, 2014 For the ... and retailer, has launched a great promotion for many ... ). Customers can get the best choice with amazing ... shopping at Tidebuy.com. , It is easy to ... now. Besides that, this selection is also famous for ...
(Date:11/23/2014)... Pro Ace Care, a renowned Vancouver hot water tank company, ... 8 year warranty on its selected hot water tanks. As ... to the impending winter season, it was important for Pro ... that the company provides. As a result, Pro Ace will ... Bradford hot water tanks. , “Every installer who works ...
(Date:11/23/2014)... 2014 (HealthDay News) -- The holidays can be a ... overload can trigger major meltdowns, an expert says. ... of circumstances, but when you have children with special ... occupational therapy professor at University of the Sciences in ... best to let your hosts or visitors know what ...
(Date:11/23/2014)... To show thanks to new and old customers, ... white evening dresses for weddings. Customers who need custom ... is a distinguished dress manufacturer, and it is among the ... for a very long time. The CEO of this company ... be able to buy not only a beautiful dress, but ...
(Date:11/23/2014)... November 23, 2014 AngelWeddingDress.com ... a new selection of beach wedding dresses. “If you ... prices, visit AngelWeddingDress.com as soon as possible. Here you ... The sales manager says. , Holding a big marriage ... And choosing a beautiful beach wedding dress is uppermost ...
Breaking Medicine News(10 mins):Health News:Beautiful Wedding Dresses Available at Popular B2C Company Tidebuy 2Health News:Pro Ace Care Now Gives 8 Year Guarantee on Selected Vancouver Hot Water Tanks 2Health News:Holidays Can Be Sensory Overload for Kids With Autism 2Health News:iFitDress.com: Wonderful White Evening Dresses Now Available 2Health News:Beach Wedding Dresses Added to Outstanding Online Dress Company AngelWeddingDress.com 2
... Reveal Deficiencies in Care for Individuals across the Country , ... Members who recently sought expert medical consultations from Best ... course of treatment, according to data released today. , ... clinical reviews of cases of Best Doctors members. Best Doctors ...
... Need to Reduce Disparities in Meningococcal Vaccination; Increase Educational ... Md., Dec. 2 The National Foundation ... Outreach. Protect.) Meningitis! coalition, composed of many ... issued a Call to Action to improve adolescent meningococcal ...
... workers, people affected by jet leg , , TUESDAY, Dec. 2 ... insomnia caused by jet lag or night shifts, according to ... II study included 39 people randomly assigned to receive either ... tasimelteon, or a placebo. They were monitored for seven nights ...
... a prototype blood scanner that can find cancer markers ... potentially allowing for earlier treatment and dramatically improved chances ... chips can find cancer-associated proteins in a blood serum ... greater sensitivity than existing commercial devices. In fact, the ...
... new naming structure, Kessler Foundation continues to improve the ... , WEST ORANGE, N.J.Dec. 2 ... disabilities, Henry H. Kessler Foundation, announced today the organization,s ... changing the names of its two main divisions to ...
... , , NEW YORK, Dec. ... JNPC; "Juniper") Sorpresa! , America,s fastest-growing Spanish-language ... Juega Como un MLS Pro , the climax of the ... 7th at 7 PM EST. , , ...
Cached Medicine News:Health News:Consumers Uncertain About Their Medical Diagnosis & Treatment 2Health News:Consumers Uncertain About Their Medical Diagnosis & Treatment 3Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 2Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 3Health News:NFID Expands Educational Efforts To Reach Racial, Ethnic Families About Dangers of Meningitis 4Health News:Drug Effective for Temporary Sleep Disruptions 2Health News:Stanford blood scanner detects even faint indicators of cancer 2Health News:Stanford blood scanner detects even faint indicators of cancer 3Health News:Henry H. Kessler Foundation Rebranded as Kessler Foundation 2Health News:Henry H. Kessler Foundation Rebranded as Kessler Foundation 3Health News:Sorpresa! Premieres Juega Como un MLS Pro 2
... offers accuracy, speed, ease of use, ... is an Auto Refractor/Keratometer with both ... elevation, automatic alignment, focusing, printing, high-speed ... other features that have made the ...
Neomycin and Polymyxin B Sulfates and Hydrocortisone ophthalmic suspension is a sterile antimicrobial and anti-inflammatory suspension for ophthalmic use....
Fluorometholone ophthalmic suspension USP, 0.1% is a topical anti-inflammatory agent for ophthalmic use....
... tool that allows to see the fundus ... stimulated. Besides it also includes the refractive ... between the pupil picture and the fundus ... is especially suited for animal research and ...
Medicine Products: